Leinco Technologies is a leader in the development and manufacturing of antibodies and recombinant proteins for early discovery research and diagnostics. In response to the ongoing worldwide pandemic, Leinco Technologies offers an extensive line of SARS-CoV-2 antibodies and antigens at the highest functional purity levels you have come to know and trust. Leinco’s COVID-19 Neutralization MICRO-ELISA and COVID-19 IgG Serology Assay has completed Section IV.D notification process under FDA’s “Policy for Coronavirus Disease – 2019 Test During the Public Health Emergency (Revised)“ and has not been reviewed by FDA.

SARS-CoV-2 (COVID-19)
Clone
Format
Reactive Species
Specificity
Host Species
Product Type
Reported Applications

Can't find what you're looking for?

Contact Leinco Technologies

10 per page
Sort by

Toggle Details

Showing 81 – 82 of 82 results Showing all 82 results Showing the single result No results found
- -
- -
Name
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
Spike Protein, S2 Subunit
Reactivity:
SARS-CoV-2
Virus
ELISA
S850
Max:
Min: 1
Step: 1
Alt Names:
Spike Protein, S Protein, Trimeric Spike Protein, Trimer
Reactivity:
SARS-CoV-2
Virus
ELISA
S848
Max:
Min: 1
Step: 1
189